Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada. more
Time Frame | BHC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.35% | -2.12% | -3% |
1-Month Return | -8.79% | -3.42% | -0.73% |
3-Month Return | -6.97% | -11.13% | 2.87% |
6-Month Return | 11% | -5.74% | 7.17% |
1-Year Return | 3.03% | 3.97% | 25.31% |
3-Year Return | -70.93% | 1.05% | 28.38% |
5-Year Return | -75.1% | 34.37% | 81.89% |
10-Year Return | -94.82% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 8.60B | 8.03B | 8.43B | 8.12B | 8.76B | [{"date":"2019-12-31","value":98.22,"profit":true},{"date":"2020-12-31","value":91.66,"profit":true},{"date":"2021-12-31","value":96.31,"profit":true},{"date":"2022-12-31","value":92.77,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 2.35B | 2.25B | 2.39B | 2.36B | 2.56B | [{"date":"2019-12-31","value":91.83,"profit":true},{"date":"2020-12-31","value":87.89,"profit":true},{"date":"2021-12-31","value":93.55,"profit":true},{"date":"2022-12-31","value":92.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 6.25B | 5.78B | 6.04B | 5.76B | 6.20B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":92.43,"profit":true},{"date":"2021-12-31","value":96.62,"profit":true},{"date":"2022-12-31","value":92.15,"profit":true},{"date":"2023-12-31","value":99.15,"profit":true}] |
Gross Margin | 72.68% | 71.98% | 71.61% | 70.90% | 70.78% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":99.04,"profit":true},{"date":"2021-12-31","value":98.54,"profit":true},{"date":"2022-12-31","value":97.56,"profit":true},{"date":"2023-12-31","value":97.39,"profit":true}] |
Operating Expenses | 6.34B | 4.46B | 4.84B | 4.40B | 5.24B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":70.45,"profit":true},{"date":"2021-12-31","value":76.34,"profit":true},{"date":"2022-12-31","value":69.51,"profit":true},{"date":"2023-12-31","value":82.62,"profit":true}] |
Operating Income | (73.00M) | 676.00M | 1.21B | 1.37B | 963.00M | [{"date":"2019-12-31","value":-5.33,"profit":false},{"date":"2020-12-31","value":49.34,"profit":true},{"date":"2021-12-31","value":88.32,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":70.29,"profit":true}] |
Total Non-Operating Income/Expense | (3.36B) | (3.13B) | (2.89B) | (2.95B) | (2.65B) | [{"date":"2019-12-31","value":-336400000000,"profit":false},{"date":"2020-12-31","value":-313100000000,"profit":false},{"date":"2021-12-31","value":-289300000000,"profit":false},{"date":"2022-12-31","value":-294900000000,"profit":false},{"date":"2023-12-31","value":-265500000000,"profit":false}] |
Pre-Tax Income | (1.84B) | (934.00M) | (1.02B) | (129.00M) | (390.00M) | [{"date":"2019-12-31","value":-183700000000,"profit":false},{"date":"2020-12-31","value":-93400000000,"profit":false},{"date":"2021-12-31","value":-102400000000,"profit":false},{"date":"2022-12-31","value":-12900000000,"profit":false},{"date":"2023-12-31","value":-39000000000,"profit":false}] |
Income Taxes | (54.00M) | (375.00M) | (87.00M) | 83.00M | 221.00M | [{"date":"2019-12-31","value":-24.43,"profit":false},{"date":"2020-12-31","value":-169.68,"profit":false},{"date":"2021-12-31","value":-39.37,"profit":false},{"date":"2022-12-31","value":37.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | (1.78B) | (559.00M) | (937.00M) | (212.00M) | (611.00M) | [{"date":"2019-12-31","value":-178300000000,"profit":false},{"date":"2020-12-31","value":-55900000000,"profit":false},{"date":"2021-12-31","value":-93700000000,"profit":false},{"date":"2022-12-31","value":-21200000000,"profit":false},{"date":"2023-12-31","value":-61100000000,"profit":false}] |
Income From Continuous Operations | (1.78B) | (559.00M) | (937.00M) | (212.00M) | (611.00M) | [{"date":"2019-12-31","value":-178300000000,"profit":false},{"date":"2020-12-31","value":-55900000000,"profit":false},{"date":"2021-12-31","value":-93700000000,"profit":false},{"date":"2022-12-31","value":-21200000000,"profit":false},{"date":"2023-12-31","value":-61100000000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.78B) | (559.00M) | (937.00M) | (212.00M) | (592.00M) | [{"date":"2019-12-31","value":-178300000000,"profit":false},{"date":"2020-12-31","value":-55900000000,"profit":false},{"date":"2021-12-31","value":-93700000000,"profit":false},{"date":"2022-12-31","value":-21200000000,"profit":false},{"date":"2023-12-31","value":-59200000000,"profit":false}] |
EPS (Diluted) | 4.37 | 3.99 | 4.45 | 3.08 | 3.51 | [{"date":"2019-12-31","value":98.2,"profit":true},{"date":"2020-12-31","value":89.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":69.21,"profit":true},{"date":"2023-12-31","value":78.88,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
BHC | |
---|---|
Cash Ratio | 0.16 |
Current Ratio | 1.19 |
Quick Ratio | 0.82 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BHC | |
---|---|
ROA (LTM) | 4.15% |
ROE (LTM) | -2304.54% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BHC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.01 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.04 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BHC | |
---|---|
Trailing PE | NM |
Forward PE | 1.78 |
P/S (TTM) | 0.29 |
P/B | 18.78 |
Price/FCF | 8 |
EV/R | 2.48 |
EV/Ebitda | 8.86 |
PEG | 0.63 |
Bausch Health Companies Inc (BHC) share price today is $7.47
Yes, Indians can buy shares of Bausch Health Companies Inc (BHC) on Vested. To buy Bausch Health Companies Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BHC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bausch Health Companies Inc (BHC) via the Vested app. You can start investing in Bausch Health Companies Inc (BHC) with a minimum investment of $1.
You can invest in shares of Bausch Health Companies Inc (BHC) via Vested in three simple steps:
The 52-week high price of Bausch Health Companies Inc (BHC) is $11.46. The 52-week low price of Bausch Health Companies Inc (BHC) is $3.96.
The price-to-earnings (P/E) ratio of Bausch Health Companies Inc (BHC) is
The price-to-book (P/B) ratio of Bausch Health Companies Inc (BHC) is 18.78
The dividend yield of Bausch Health Companies Inc (BHC) is 0.00%
The market capitalization of Bausch Health Companies Inc (BHC) is $2.72B
The stock symbol (or ticker) of Bausch Health Companies Inc is BHC